News Conference News ESC 2017 Women at High Cardiovascular Risk Unlikely to Get to Low LDL Targets Michael O'Riordan August 30, 2017
News Conference News ESC 2017 Ultra-Low LDL Levels? FOURIER Suggests Efficacy of Evolocumab Michael O'Riordan August 28, 2017
News Conference News ESC 2017 CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events Michael O'Riordan August 27, 2017
News Daily News 3-D Ultrasound Quantifies Plaque Burden in Healthy Middle-Aged Cohort Michael O'Riordan July 11, 2017
News Daily News Therapies Aimed at New Genetic Target Show Early Promise for Lowering Triglycerides Todd Neale May 26, 2017
News Conference News EAS 2017 FOURIER in Focus: Costs, Patient Selection, Combination Therapy, and Safety Debated as Lipid Experts Digest the Data Yael L. Maxwell April 26, 2017
News Daily News ACC/AHA ‘Very High Risk’ Criteria Only Modestly Predict Recurrent Events Michael O'Riordan April 04, 2017
News Conference News ACC 2017 Low HDL Cholesterol Common in Young MI Patients, With Young Women Faring Worse Long-Term Michael O'Riordan March 10, 2017
News Conference News ISC 2017 Early Statin Therapy Fails to Boost Acute Stroke Outcomes, but Trial Methods Questioned Todd Neale February 24, 2017
News Daily News How Low Can Cholesterol Go? Safety Not in Limbo for Patients With Very Low LDL on Alirocumab, Study Shows Yael L. Maxwell January 31, 2017
News Daily News Younger Adults With Severe Dyslipidemia Less Likely to Be Prescribed Statins Michael O'Riordan January 05, 2017